ESC: Ultrathin Stent Proves Mettle in Post-PCI Patients (CME/CE)

BARCELONA (MedPage Today) -- An ultrathin biodegradable sirolimus-eluting stent (Orsiro) proved noninferior to a durable polymer everolimus-eluting stent (Xience) a year after percutaneous coronary intervention (PCI), researchers reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news